Twenty-five years of research on the effects of exercise training in breast cancer survivors: A systematic review of the literature

Table 2 2000-2006 study results summary

Measure	No. of studies	N	Baseline		Post-intervention		Change		P
			Mean	SD	Mean	SD	Mean	95%CI
Cardiorespiratory function
Bike VO2peak (mL/kg per minute)
Exercise	5	81	23.26	2.95	25.40	2.75	2.14	-4.28	0.000
Control	2	36	23.10	6.08	21.95	5.30	-1.15	-13.98	0.284
Bike VO2peak (L/min)
Exercise	1	22	1.67	0.35	1.81	0.37	0.14	-	-
Control	1	19	1.6	0.36	1.63	0.35	0.03	-	-
Est. Treadmill. VO2peak (mL/kg per minute)
Exercise	1	40	30.58	-	35.20	-	4.62	-	-
Control	0		-		-
VO2peak (L/min)
Exercise	1	22	1.67	-	1.81	-	0.14	-	-
Control	1	19	1.6	-	1.63	-	0.03	-	-
mCAFT VO2peak (mL/kg per minute)
Exercise	1	82	25.7	0.28	26.45	0.49	-0.75	-	-
Control	1	41	25.1	6.10	25.10	6.10	0.00	-	-
12-min walk test (m)
Exercise	2	56	1032.35	8.98	1264.8	126.15	232.45	-2428.16	0.248
Control	2	37	1045.2	59.11	944.8	194.03	-100.4	-2424.34	0.484
6-min walk test (m)
Exercise	1	9	672.9	-	776.03	-	103.13	-	-
Control	0
1 mile walk test (min)
Exercise	1	43	17.45	-	16.34	-	-1.11	-	-
Control	1	43	17.65	-	17.85	-	0.20	-	-
Body composition
Body mass (kg)
Exercise	9	248	69.47	10.36	68.43	9.54	-1.04	-2.83	0.131
Control	7	183	75.80	6.46	76.64	6.31	0.84	-2.62	0.166
Fat mass (kg)
Exercise	4	75	25.95	9.73	23.93	8.57	-2.03	-7.57	0.187
Control	3	73	32.90	8.18	33.20	6.52	-0.30	-8.44	0.789
Body fat (%)
Exercise	8	218	33.82	8.25	32.31	8.03	1.51	0.37-2.66	0.017
Control	6	165	36.48	9.29	36.66	8.96	0.18	-2.03	0.673
Strength
1RM UB composite (kg)
Exercise	1	21	9.1	1.93	10.16	2.08	0.96	-	-
Control	1	15	8.77	1.75	8.59	1.29	-0.18	-	-
1RM UB (kg)
Exercise	2	67	22.63	10.15	30.23	13.39	7.61	-58.33	0.187
Control	0
1RM LB (kg)
Exercise	3	76	99.87	31.29	133.19	57.10	33.32	-141.42	0.180
Control	0
Psychosocial Measures
FACT-G
Exercise	2	37	78.75	9.55	87.60	5.23	8.85	-77.50	0.211
Control	2	38	83.90	6.93	82.70	9.33	-1.20	-43.20	0.609
FACT-B
Exercise	3	47	100.3	9.30	111.03	7.42	10.73	-15.37	0.027
Control	2	38	105.75	13.79	105.05	15.20	-0.70	-25.42	0.611
SF-36
Exercise	1	42	76.30	0.28	94.75	8.98	18.45	-	-
Control	1	41	83.50	-	102.4	-	18.90	-	-
WHO-QOL BREF
Exercise	1	27	8.2	0.92	8.8	0.78	0.60	-	-
Control	0
PFS
Exercise	2	22	5.07	0.24	3.47	0.47	-1.61	0.50-4.81	0.194
Control	1	10	4.87	2.50	4.62	2.50	-0.25	-	-
SCFS
Exercise	1	44	10.70	3.75	10.20	6.00	-0.50	-	-
Control	1	27	10.80	0.00	13.40	5.60	2.60	-	-
LAS
Exercise	1	43	42.47	23.54	27.08	21.41	-15.39	-	-
Control	1	43	41.66	25.04	42.28	26.20	0.62	-	-
BDI
Exercise	1	40	5.84	4.90	3.92	4.00	-1.92	-	-
Control	0
HRSD
Exercise	1	40	9.46	6.00	6.10	5.00	-3.36	-	-
Control	0

VO_2peak: Peak oxygen uptake; mCAFT: Modified Canadian Fitness Test; UB composite: Upper body combined strength measures; UB: Upper body strength test; LB: Lower body strength test; EORTC: European Organization for Research and Treatment of Cancer; FACT-G: Functional Assessment of Cancer Therapy-General; FACT-B: Functional Assessment of Cancer Therapy-Breast; SF-36: Short-Form-36; WHO-QOL BREF: The World Health Organization-BREF Quality of Life Instrument; PFS: Piper Fatigue Scale; SCFS: Schwartz Cancer Fatigue Scale; LAS: Linear Analog Scale; BDI: Beck Depression Inventory; HRSD: The Hamilton Rating Scale for Depression; Est. Treadmill VO_2peak: VO_2peak estimated via submaximal CPET; CPET: Cardiopulmonary exercise test.